These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2706639

  • 1. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.
    Griffin TW, Bokhari F, Collins J, Stochl M, Bernier M, Gionet M, Siebecker D, Wertheimer M, Giroves ES, Greenfield L.
    Cancer Immunol Immunother; 1989; 29(1):43-50. PubMed ID: 2706639
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
    Rosenblum MG, Murray JL, Haynie TP, Glenn HJ, Jahns MF, Benjamin RS, Frincke JM, Carlo DJ, Hersh EM.
    Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
    [Abstract] [Full Text] [Related]

  • 3. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
    Griffin TW, Brill AB, Stevens S, Collins JA, Bokhari F, Bushe H, Stochl MC, Gionet M, Rusckowski M, Stroupe SD.
    J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
    Rosenblum MG, Murray JL, Lamki L, David G, Carlo D.
    Cancer Chemother Pharmacol; 1987 Apr; 20(1):41-7. PubMed ID: 3621452
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG, Verschraegen CF, Murray JL, Kudelka AP, Gano J, Cheung L, Kavanagh JJ.
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
    Longley C, Furmanski P, Dienhart DG, Lear J, Bloedow D, Kasliwal R, Bunn PA.
    Cancer Res; 1990 Sep 15; 50(18):5954-61. PubMed ID: 2393864
    [Abstract] [Full Text] [Related]

  • 10. Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.
    Pai-Scherf LH, Carrasquillo JA, Paik C, Gansow O, Whatley M, Pearson D, Webber K, Hamilton M, Allegra C, Brechbiel M, Willingham MC, Pastan I.
    Clin Cancer Res; 2000 May 15; 6(5):1720-30. PubMed ID: 10815890
    [Abstract] [Full Text] [Related]

  • 11. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM.
    Cancer Res; 2000 Sep 01; 60(17):4804-11. PubMed ID: 10987290
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.
    Beatty BG, O'Conner-Tressel M, Do T, Paxton RJ, Beatty JD.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):846s-851s. PubMed ID: 2297732
    [Abstract] [Full Text] [Related]

  • 13. A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
    Wong JY, Raubitschek A, Yamauchi D, Williams LE, Wu AM, Yazaki P, Shively JE, Colcher D, Somlo G.
    Cancer Biother Radiopharm; 2010 Aug 01; 25(4):387-94. PubMed ID: 20707718
    [Abstract] [Full Text] [Related]

  • 14. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR, Babich J, Young H, Waddington W, Clarke G, Short M, Boulos P, Styles J, Dean C.
    Br J Cancer; 1991 Nov 01; 64(5):850-6. PubMed ID: 1931605
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA.
    J Nucl Med; 1997 Dec 01; 38(12):1951-9. PubMed ID: 9430476
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of an indium-labeled IgG monoclonal antibody over a prolonged period.
    Halpern SE, Bartholomew R.
    Eur J Nucl Med; 1995 Nov 01; 22(11):1323-5. PubMed ID: 8575485
    [Abstract] [Full Text] [Related]

  • 17. Localization of sarcoma xenografts in nude mice with indium-111-labeled monoclonal antibodies.
    Chao TC, Blend MJ, Lopes AD, Atcher RW, Das Gupta TK, Greager JA.
    J Surg Res; 1993 Jul 01; 55(1):38-43. PubMed ID: 8412080
    [Abstract] [Full Text] [Related]

  • 18. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB.
    Cancer Biother Radiopharm; 2001 Oct 01; 16(5):371-9. PubMed ID: 11776754
    [Abstract] [Full Text] [Related]

  • 19. Intraperitoneal 131I- and 111In-791T/36 monoclonal antibody in recurrent ovarian cancer: imaging and biodistribution.
    Perkins AC, Pimm MV, Gie C, Marksman RA, Symonds EM, Baldwin RW.
    Nucl Med Commun; 1989 Aug 01; 10(8):577-84. PubMed ID: 2812640
    [Abstract] [Full Text] [Related]

  • 20. Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.
    Kramer EL, Liebes L, Wasserheit C, Noz ME, Blank EW, Zabalegui A, Melamed J, Furmanski P, Peterson JA, Ceriani RL.
    Clin Cancer Res; 1998 Jul 01; 4(7):1679-88. PubMed ID: 9676842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.